Patent ID: 11935637
Assignee: INSULET CORPORATION
Field: Medical technology (Instruments)
Classification: CPC G  A | IPC A  G

Claim 5:
6. The non-transitory computer readable medium of claim 1, further embodied with further programming code as part of the artificial pancreas application executable by the processor, and the processor when executing the further programming code is operable to perform further functions, including functions to:
retrieve new information related to an amount of insulin delivered by the drug delivery device as part of an updated insulin delivery history, wherein the updated insulin delivery history is a sufficient insulin delivery history;
determine that an adaptivity mode is inactive;
in response to determining the adaptivity mode is inactive, set a total daily insulin dosage at a daily average based on the retrieved new information;
set the adaptivity mode to active; and
provide the set total insulin dosage to the drug delivery device.